17 November 2025 : Clinical Research
Association of Hyperuricemia with Cardiovascular Risk Factors and Cardiac Structural Changes in Patients Undergoing Maintenance Hemodialysis in Southwest China
Wei Pan ABCEG 1*, Kaiyan Wu BCE 1,2, Yan Zeng BCD 1, Yinglan Liang BCD 1, Xiaomei Du BCD 1, Keqin Hu BCD 1, Hui Fan BCD 1, Qiongdan Hu ADEG 1, Qiong Zhang ADEG 1DOI: 10.12659/MSM.949422
Med Sci Monit 2025; 31:e949422
Table 10 Cardiac functions in patients undergoing maintenance hemodialysis with normal blood uric acid and with hyperuricemia (HUA).
| Indicators of cardiac function | Non-HUA Group | HUA Group | t | P |
|---|---|---|---|---|
| LVPWd (mm) | 10.75±2.27 | 12.14±1.54 | 9.757 | 0.003 |
| IVSd (mm) | 10.21±2.55 | 12.92±1.34 | −2.107 | 0.015 |
| LVEDD (mm) | 50.17±6.41 | 54.88±4.13 | −2.380 | 0.032 |
| LVESD (mm) | 36.58±9.27 | 34.44±7.12 | 0.750 | 0.365 |
| LVEF (%) | 56.25±10.25 | 46.88±5.64 | 2.943 | 0.010 |
| LVPWd – left ventricular posterior wall thickness; IVSd – interventricular septum thickness; LVEDD – left ventricular end-diastolic diameter; LVESD – left ventricular end-systolic diameter; LVEF – left ventricular ejection fraction. | ||||